N
NeuroKaire
About
Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.
Tags
Total Employees
31
Current headcount
Company Timeline
Funding rounds, employee growth, revenue, and exits over the same period. News mentions shown as markers.
No timeline data for this period
Score Breakdown
48Traction
50Team
70Visibility
28Profile
80Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does NeuroKaire do?
Genetika+ is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The Genetika+ test uses innovative technology to predict the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing. (formerly Genetika+.)
How much funding has NeuroKaire raised?
NeuroKaire has raised a total of $10M in funding. The most recent round on record is Grant.
When was NeuroKaire founded?
NeuroKaire was founded in 2017.
What industry does NeuroKaire operate in?
NeuroKaire operates in Neuroscience, Biotech, Mental Health, Drug Therapy, Depression, Personalized Treatment.
How many employees does NeuroKaire have?
NeuroKaire has approximately 31 people on record.